IP Library Granted Patent US 7,842,279
Granted Patent B2
US 7,842,279 · App. 11/500,774 · Granted Nov 30, 2010

F-18 peptides for pre targeted positron emission tomography imaging

Assignee: Immunomedics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,279
App. No.
11/500,774
Granted
Nov 30, 2010
Kind
B2
Abstract

F-18 radiolabeled peptides are prepared by reacting a peptide comprising a hydroxylamine, a thiosemicarbazide, a hydrazine or a free amine group with 4-[ 18 F]Fluorobenzaldehyde. Specific, non-limiting examples of F-18 radiolabeled peptides are described herein. The labeled peptides are useful, for example, in clinical positron emission tomography.

Claims (13)

1. A method of radiolabeling a protein or peptide comprising a nucleophilic nitrogen atom, comprising:

a) contacting said protein or peptide with a bisulfate addition complex of [ 18 F]Fluorobenzaldehyde; and

b) forming a carbon-nitrogen double bond between said nucleophilic nitrogen atom and said [ 18 F]Fluorobenzaldehyde.

2. The method of claim 1 , wherein said nucleophilic nitrogen atom is part of a moiety selected from the group consisting of a primary amine, a secondary amine, a hydroxylamine, a thiosemicarbazide and a hydrazine.

3. The method of claim 1 , further comprising reducing said double bond with a reducing agent.

4. The method of claim 1 , wherein the protein or peptide is an antibody or antibody fragment.

5. The method of claim 1 , wherein the bisulfite addition complex of [ 18 F]Fluorobenzaldehyde is formed by reacting 4-[ 18 F]fluorobenzaldehyde with sodium bisulfite.

6. The method of claim 1 , wherein a solution containing the bisulfite addition complex of [ 18 F]Fluorobenzaldehyde is evaporated to dryness to concentrate the bisulfite addition complex before it is contacted with the protein or peptide.

7. The method of claim 1 , wherein the bisulfite addition complex of [ 18 F]Fluorobenzaldehyde is contacted with the protein or peptide in an aqueous medium to form a mixture.

8. The method of claim 7 , wherein the mixture is heated.

9. The method of claim 8 , wherein the mixture is heated to 100° C.

10. The method of claim 3 , wherein the reducing agent is sodium cyanoborohydride.

11. The method of claim 1 , wherein the peptide is selected from the group consisting of IMP 286, IMP 316, IMP 318, IMP 319, IMP 320, IMP 321, IMP 322, IMP 327, IMP 328 and IMP 330.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2006
From: MCBRIDE, WILLIAM J.; NOREN, CARL F.
To: IMMUNOMEDICS, INC.
Reel/Frame 018274/0281 →
Continuity (2)
Provisional Application 6071243300 · Aug 31, 2005
Related Publication 20070048217A1 · Mar 1, 2007